Biogen Cash Conversion Cycle 2011-2026 | BIIB

Annual Cash Conversion Cycle Biogen

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
387	277	188	177	141	114	180	183	234	236	238	244	226	169

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
387	114	214

Quarterly Cash Conversion Cycle Biogen

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
283	285	300	358	393	237	129	175	-	237	214	153	-	216	216	95.8	61.2	176	184	138	46.7	106	99.8	113	50.7	163	174	164	49.3	178	179	52.4	45.8	44.5	45.5	44.6	39.4	40.3	43.2	45	44.7	47	48.7	45.4	38.3	41.2	43.6	282	44.2	205	204	176	40.2	144	172	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
393	38.3	135

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Adagene ADAG	53.8	$ 1.65	7.91 %	$ 92.9 M	China
Arrowhead Pharmaceuticals ARWR	8.75	$ 66.05	2.3 %	$ 8.83 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	-58	$ 93.52	-1.2 %	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Bristol-Myers Squibb Company BMY	60.4	$ 55.71	-0.28 %	$ 113 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Zai Lab Limited ZLAB	-94.2	$ 18.37	-0.97 %	$ 18.2 B	China
Coherus BioSciences CHRS	326	$ 1.61	-5.03 %	$ 152 M	USA
Catalyst Biosciences CBIO	391	$ 10.84	0.46 %	$ 714 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	-6.08 K	$ 25.59	-6.54 %	$ 1.65 M	USA
Cellectis S.A. CLLS	-839	$ 4.22	-4.2 %	$ 116 M	France
Clearside Biomedical CLSD	-1.67 K	-	-	$ 25.3 M	USA
Chimerix CMRX	588	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Corcept Therapeutics Incorporated CORT	-186	$ 37.35	-0.4 %	$ 3.86 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 23.18	2.02 %	$ 2.75 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Crinetics Pharmaceuticals CRNX	2 K	$ 55.11	3.49 %	$ 4.45 B	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 55.17	2.47 %	$ 4.65 B	Schweiz
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 29.43	6.09 %	$ 1.43 B	USA